Navigation Links
Curemark to Present at the Rodman & Renshaw Annual Global Investment Conference
Date:8/16/2010

.  In addition to healthcare, the conference will highlight industry tracks including China, metals and mining, energy, technology, cleantech, community and regional banks, and REITs.

About CUREMARK LLC

Curemark is a drug research and development company focused on the treatment of neurological and other diseases, especially those with dysautonomic components, by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of protein digestion in children with autism and ADHD. To learn more about our innovative science, visit www.curemark.com.

Safe Harbor Statement

This news release contains forward-looking statements that involve risks and uncertainties that could cause our actual results and experiences to differ materially from anticipated results and expectations expressed in such forward-looking statement. These forward-looking statements include, without limitation, statements regarding the mechanism of action of CM-AT, its potential advantages, its potential for use in treating autism, as well as the timing, progress and anticipated results of the clinical development and regulatory processes concerning CM-AT. These statements are based on our current beliefs and expectations as to such future outcomes, and are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. Factors that might cause such a material difference include, among others, risks that the results of clinical trials will not support our claims or beliefs concerning the effectiveness of CM-AT, our ability to finance our development of CM-AT, regulatory risks, and our reliance on third party researchers and other collaborators. We assume no obligation to update these statement
'/>"/>

SOURCE Curemark, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Curemark Opens Autism Trials at New Jersey Site
2. Curemark Begins Autism Trials at Two More Sites
3. Dr. Joan Fallon, Curemark CEO, Addresses Keystone Symposia Meeting On Autism
4. Curemark Adds UC Davis MIND Institute to Autism Clinical Trial Sites
5. Curemark CM-AT Autism Treatment Granted FDA Fast Track Status
6. Curemark Enrolling Patients In Phase III Autism Trials At Ten Sites
7. Curemark Opens Patient Enrollment for Autism Treatment at Three More Clinical Trial Sites
8. Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment
9. Curemark Announces Senior Executive Promotions
10. Curemark CEO Presents at Epigenomics Conference
11. Curemark Closes Series A Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 Aufgrund der enormen ... erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt auch die Jahre ... unter pharmaserialisation.com , zeigt die Serialisierungsanforderungen weltweit ... Kraft treten. Für international tätige Unternehmen ... das "ob", sondern darum, "wann" sie die neu ...
(Date:9/19/2014)... , Sept. 19, 2014  CytRx Corporation (Nasdaq: ... company specializing in oncology, today announced that David ... at BioCentury,s 2014 NewsMakers in the Biotech Industry Conference on ... Time. The conference will take place at the Millennium ... . A live and archived webcast of ...
(Date:9/19/2014)...  PCI is pleased to announce it has ... leading provider of Clinical Trial Services and Temperature ... Wales in the United ... presence in the UK/EU to support global investigational ... and distribution capacity, as well as consultative services ...
Breaking Medicine Technology:Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6
... SANTA ROSA, Calif., Oct. 31, 2011 Claret Medical, ... CE Mark approval as the world,s first complete system ... 6F catheter is delivered via radial or brachial access, ... Transcatheter Aortic Valve Intervention (TAVI).  The unique design of ...
... is pleased to announce that it has been awarded a ... Institute,s (NCI) Small Business Innovation Research (SBIR) program to help ... Over the past 20 years, PET has evolved into a ... cancer but many important areas of oncology still lack effective ...
Cached Medicine Technology:Claret Medical Announces CE Mark of a New Embolic Protection System to Address Stroke During Transcatheter Aortic Valve Intervention 2ImaginAb, Inc. Awarded $2.3 Million from the National Cancer Institute 2
(Date:9/20/2014)... (PRWEB) September 20, 2014 Villa del ... resort did not experience any damage in relation to ... and activities available. , Hurricane Odile struck Cabo San ... wind, rain and powerful surf conditions. Located on the ... Islands of Loreto experienced some heavy rain, but no ...
(Date:9/20/2014)... On Monday, September 22, Loma Linda ... research grant from Hyundai Hope on Wheels at a ... located on 11234 Anderson St., in Loma Linda. The ... Associate Professor at Loma Linda University and Director of ... children. , Loma Linda University Medical Center ...
(Date:9/20/2014)... (HealthDay News) -- The avian flu that killed 160 ... spread through respiratory drops and therefore poses a potential ... Although no human illnesses have been linked to the ... hospital have discovered natural mutations to the avian H3N8 ... the air in droplets. Current seasonal flu vaccines ...
(Date:9/20/2014)... New PharmaPoint Drug Evaluation report, ... 2023?. The asthma market saw very slow growth ... saturated with relatively efficacious standard therapies, such as ... and long-acting beta-agonists (ICS/LABAs), and leukotriene modifiers, and ... the launch of seven novel targeted biologic agents ...
(Date:9/20/2014)... NC (PRWEB) September 20, 2014 The excitement is ... in Mount Airy, North Carolina. This year the Surry Arts ... draws people from around the country who are still fans of ... Show is a sitcom that aired on CBS from 1960 through ... best show in American television history. Mount Airy, North Carolina ...
Breaking Medicine News(10 mins):Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 3Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 3Health News:Avian Flu In Harbor Seals Could Infect People 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 3Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 4Health News:Mayberry Days Parade Cars will be Provided by Mount Airy Toyota and Mount Airy Chrysler Dodge Jeep Ram 2
... the primary cause of deaths from pneumonia in developing countries ... to a comprehensive new analysis to be released on Thursday, ... International Health , the authors estimate that two pneumococcal ... from the GAVI Alliance could save the lives of three ...
... -- The human jaw shrinks with age and that can result ... found. Swedish researchers looked at plaster molds made of the ... their 20s, and follow-up jaw molds of the same people made ... years there was less and less room for teeth in the ...
... Reporter , WEDNESDAY, Nov. 9 (HealthDay News) -- For the ... solid tumors, in this case non-small cell lung cancers. ... two had a complete response to therapy, one had a ... years after starting therapy. "It,s not a home run, ...
... new study released today offers hope that California may finally ... obesity, but it also showcases a patchwork of progress that ... in obesity rates among school-age children. According ... and Obesity Among California 5th, 7th and 9th Graders, 2005�," ...
... A clinical trial comparing prasugrel to clopidogrel for ... coronary intervention (PCI) was ended early due to relatively ... the primary endpoint at six month follow up. ... In patients underGoing elective stent placement on clopidogrel to ...
... Calif. With an estimated 1.5 million species, fungi represent ... Life . They have an enormous impact on human affairs ... and pathogens, and their partnership with host organisms for mutual ... an accurate understanding of what exactly they do, how they ...
Cached Medicine News:Health News:New studies show progress, value in vaccination against deadly pneumonia 2Health News:New studies show progress, value in vaccination against deadly pneumonia 3Health News:New studies show progress, value in vaccination against deadly pneumonia 4Health News:New Treatment May Boost Survival in Advanced Lung Cancer Cases 2Health News:New Treatment May Boost Survival in Advanced Lung Cancer Cases 3Health News:California making headway in battle against childhood obesity but successes are uneven 2Health News:Results of the TRIGGER-PCI trial reported at TCT 2011 2Health News:International team to sequence genomes of fungi 2Health News:International team to sequence genomes of fungi 3
UROSKOP Access, the dedicated urodiagnostic table with truly unrestricted patient access optimizes nearly all diagnostic and interventional procedures....
Drew Scientific has been making leading edge and top quality CBC systems for over 15 years.,The Excell 16/18 offers a reliable alternative for a 3 part differential....
... therapeutic, expandable turning surface for the BariMaxx™ ... Prevention and treatment of pressure ulcers, Large ... patients using a statuc mattress that would ... whose body weight and size pose a ...
... The BariMaxx™ is a full-featured healthcare bed ... for the care and management of larger ... to 1000 lbs. ,Large patients at risk ... in excess of 1000 lbs. (including accessories), ...
Medicine Products: